Navigation Links
Rock concert aids cancer research
Date:1/18/2011

Rock legends The Who performed alongside Jeff Beck, Blondie singer Debbie Harry and The Verve's Richard Ashcroft. They wowed a packed house and glittering list of celebrities to raise funds for PDT.

The work carried out by Dr. Alison Curnow and her team at the Peninsula Medical School and Royal Cornwall Hospital in Truro, UK, was given an immediate grant from the Killing Cancer charity of 30,000, which came from the proceeds of the concert.

Dr. Curnow commented: "The Peninsula Medical School PDT research team and the very busy dermatology PDT service led by Dr. Sandra Campbell at the Royal Cornwall Hospital are delighted with the generous support provided by Killing Cancer. It was a fantastic show and this funding will enable us to continue our clinical PDT research for another year. PDT is still a relatively little know light-activated anti-cancer drug therapy that can be used topically to destroy certain types of skin cancer without scarring."

David Longman, director of Killing Cancer, added: "Alison's team is doing amazing work in Cornwall. The concert was a great success and it was good to be able to make an immediate grant to recognise quickly the way Alison and her team are developing the use of PDT. The charity and the rock legends who supported us wanted to recognise the incredible research work, dedication and determination of Alison and her team."


'/>"/>

Contact: Andrew Gould
andrew.gould@pcmd.ac.uk
44-139-268-6107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Page: 1

Related medicine news :

1. dbMaestro Achieves “Ready For IBM Rational Software” Validation For Rational Team Concert Integration
2. Hospitals and Health Systems Have a New Solution for Zero Footprint Image Exchange; Orion Health Announces Concerto Enterprise Image Viewer
3. U-M researchers find indirect path to attack breast cancer stem cells
4. Oncology basic research director at John Theurer Cancer Center continues transplantation research
5. Scientists bring cancer cells back under control
6. Scientists identify avoidable breast cancer risk factors
7. Clinicians cite time, patient embarrassment as barriers to performing skin cancer exams
8. Thorough Exams a Must for Those at High Risk of Skin Cancer
9. Breast Cancer Radiation Before 1984 Tied to Heart Disease
10. Study Finds Racial Disparity in Breast Cancer Outcomes
11. Study provides molecular rationale for combining targeted agents to treat breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... , ... May 26, 2017 , ... ... of the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface ... browser-based interface for diagnostic device operations. With this platform, initializing devices and importing ...
(Date:5/26/2017)... ... May 26, 2017 , ... Boar’s Head ... bold recipes for Memorial Day entertaining that are sure to satisfy your guests’ ... fresh sliced meats and cheeses featured in these refreshingly balanced recipes are packed ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... On May ... (AHCA), which narrowly passed the U.S. House on May 4, would result in 23 ... expected under continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... week that is focusing on the Peace Agreements being discussed by President Donald Trump ... in a race to try to speed up peace talks in the continuous battle ...
(Date:5/26/2017)... ... ... Rob Lowe acts as host and helps educate and inform the public using the ... can reconnect with America as it explores some of the best places to hike ... an inventive new place for a family vacation, and have discovered hiking. Many will ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... , May 17, 2017  Bayer announced today that ... will be presented at the 53 rd Annual ... taking place June 2-6 in Chicago ... ASCO span prostate, colorectal, liver and thyroid cancers, as ... the Phase II CHRONOS-1 trial of copanlisib in patients ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: